Clotilde Wiel
Goeteborg, O 41390, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
NRF2 activation by myeloid cell-derived oxidative stress induces SNAI-driven features of EMT in breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2026
Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potential.
Journal: Redox biology
Published: March 10, 2026
BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAFV600E-induced hepatocellular carcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 06, 2025
Amino acid restriction sensitizes lung cancer cells to ferroptosis via GCN2-dependent activation of the integrated stress response.
Journal: Redox biology
Published: October 17, 2025
Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening.
Journal: Discover oncology
Published: June 11, 2025
Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish Cohort.
Journal: JTO clinical and research reports
Published: April 09, 2025
Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis.
Journal: Frontiers in oncology
Published: January 31, 2025
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 22, 2024
Nuclear AGO2 supports influenza A virus replication through type-I interferon regulation.
Journal: Nucleic acids research
Published: October 30, 2024
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2024
Ageing promotes metastasis via activation of the integrated stress response.
Journal: Nature
Published: June 20, 2024
Last Updated: 09/26/2026